Mojarad M et al. |
Platelet-activating factor increases pulmonary microvascular permeability and induces pulmonary edema. A preliminary report. |
1983 May-Jun |
Bull Eur Physiopathol Respir |
pmid:6882949
|
Pazzi A et al. |
[Platelet activation in vivo. Electron microscopy study of a case of type II diabetes]. |
1983 Mar-Apr |
G Clin Med |
pmid:6884636
|
Wasserman SI |
Mediators of immediate hypersensitivity. |
1983 |
J. Allergy Clin. Immunol. |
pmid:6193157
|
Stimler NP and O'Flaherty JT |
Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues. |
1983 |
Am. J. Pathol. |
pmid:6624879
|
Hartung HP |
Acetyl glyceryl ether phosphorylcholine (platelet-activating factor) mediates heightened metabolic activity in macrophages. Studies on PGE, TXB2 and O2- production, spreading, and the influence of calmodulin-inhibitor W-7. |
1983 |
FEBS Lett. |
pmid:6309563
|
Shukla SD et al. |
Acetylglyceryl ether phosphorylcholine. A potent activator of hepatic phosphoinositide metabolism and glycogenolysis. |
1983 |
J. Biol. Chem. |
pmid:6309795
|
Hallam TJ et al. |
The role of 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (AcGEPC) and palmitoyl-lysophosphatidate in the responses of human blood platelets to collagen and thrombin. |
1983 |
FEBS Lett. |
pmid:6617886
|
Patterson R and Harris KE |
The activity of aerosolized and intracutaneous synthetic platelet activating factor (AGEPC) in rhesus monkeys with IgE-mediated airway responses and normal monkeys. |
1983 |
J. Lab. Clin. Med. |
pmid:6644157
|
Nunn B |
Total and selective desensitisation of human platelets to synthetic platelet activating factor (PAF): evidence that extracellular PAF does not mediate collagen-induced aggregation. |
1983 |
Thromb. Res. |
pmid:6648898
|
Myers A et al. |
Glucocorticoid protection against PAF-acether toxicity in mice. |
1983 |
Br. J. Pharmacol. |
pmid:6652344
|
Cervoni P et al. |
Aortic vascular and atrial responses to (+/-)-1-O-octadecyl-2-acetyl-glyceryl-3-phosphorylcholine. |
1983 |
Br. J. Pharmacol. |
pmid:6652348
|
Stormorken H et al. |
A new bleeding disorder: lack of platelet aggregatory response to adrenaline and lack of secondary aggregation to ADP and platelet activating factor (PAF). |
1983 |
Thromb. Res. |
pmid:6857589
|
Kloprogge E et al. |
Stimulus-response coupling in human platelets. Evidence against a role of PAF-acether in the "third pathway'. |
1983 |
Thromb. Res. |
pmid:6857605
|
Chilton FH et al. |
Selective acylation of lyso platelet activating factor by arachidonate in human neutrophils. |
1983 |
J. Biol. Chem. |
pmid:6408071
|
Lecrubier C et al. |
Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin. |
1983 |
Agents Actions |
pmid:6858789
|
Gonzalez-Crussi F and Hsueh W |
Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. |
1983 |
Am. J. Pathol. |
pmid:6859226
|
Hubbard JW et al. |
Antihypertensive effects of I-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine on plasma renin activity and catecholamine responses in spontaneously hypertensive rats. |
1983 |
Life Sci. |
pmid:6337313
|
Acharya SB and MacIntyre DE |
Platelet products and vascular PGI2 production. |
1983 |
Prostaglandins Leukot Med |
pmid:6338532
|
Camussi G et al. |
Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia. |
1983 |
Immunology |
pmid:6339375
|
Billah MM and Lapetina EG |
Platelet-activating factor stimulates metabolism of phosphoinositides in horse platelets: possible relationship to Ca2+ mobilization during stimulation. |
1983 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:6341992
|